UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 45

Sortiert nach

Feline umbilical cord-derived mesenchymal stem cells: isolation, identification, and antioxidative stress role through NF-κB signaling pathway

Frontiers in veterinary science, 2023-05, Vol.10, p.1203012-1203012

2023

Volltextzugriff (PDF)

Potential immune escape mechanisms underlying the distinct clinical outcome of immune checkpoint blockades in small cell lung cancer

Journal of hematology and oncology, 2019-06, Vol.12 (1), p.67-67, Article 67

2019

Volltextzugriff (PDF)

The Role of Cytokines in Predicting the Response and Adverse Events Related to Immune Checkpoint Inhibitors

Frontiers in immunology, 2021-07, Vol.12, p.670391

2021

Volltextzugriff (PDF)

The mechanism and risk factors for immune checkpoint inhibitor pneumonitis in non-small cell lung cancer patients

Cancer biology & medicine, 2020-08, Vol.17 (3), p.599-611

2020

Volltextzugriff (PDF)

Somatostatin Treatment for Ectopic ACTH Syndrome due to Pancreatic Neuroendocrine Tumors: Review of the Literature

International journal of endocrinology, 2022-02, Vol.2022, p.6283706-10

2022

Volltextzugriff (PDF)

Downregulation of lncRNA XR_429159.1 Linked to Brain Metastasis in Patients With Limited-Stage Small-Cell Lung Cancer

Frontiers in oncology, 2021-05, Vol.11, p.603271-603271

2021

Volltextzugriff (PDF)

Metabolic syndrome, intracranial arterial stenosis and cerebral small vessel disease in community-dwelling populations

Stroke and vascular neurology, 2021-12, Vol.6 (4), p.589-594

2021

Volltextzugriff (PDF)

Clinical Outcomes for PD-1 Inhibitor Plus Chemotherapy as Second-Line or Later Therapy Compared to PD-1/PD-L1 Inhibitor Alone in Advanced Non-small-cell Lung Cancer

Frontiers in oncology, 2020-09, Vol.10, p.556275

2020

Volltextzugriff (PDF)

Concurrent mutations of germline GPR101 and somatic USP8 in a pediatric giant pituitary ACTH adenoma: a case report

BMC endocrine disorders, 2022-06, Vol.22 (1), p.152-152, Article 152

2022

Volltextzugriff (PDF)

Therapeutic effect of osimertinib plus cranial radiotherapy compared to osimertinib alone in NSCLC patients with EGFR-activating mutations and brain metastases: a retrospective study

Radiation oncology (London, England), 2021-12, Vol.16 (1), p.233-233, Article 233

2021

Volltextzugriff (PDF)

Identification of three novel SRD5A2 mutations in Chinese patients with 5α-reductase 2 deficiency

Asian journal of andrology, 2019-11, Vol.21 (6), p.577-581

2019

Volltextzugriff (PDF)

Comprehensive Treatment Uncertainty Analysis and PTV Margin Estimation for Fiducial Tracking in Robotic Liver Stereotactic Body Radiation Therapy

Current medical science, 2023-06, Vol.43 (3), p.572-578

2023

Volltextzugriff (PDF)

Identification of U-shaped curve relation between proneurotensin and risk of coronary artery disease (CAD) in patients with premature CAD

Nutrition, metabolism, and cardiovascular diseases, 2020-03, Vol.30 (3), p.483-491

2020

Volltextzugriff (PDF)

Endostar (rh‐endostatin) improves efficacy of concurrent chemoradiotherapy for locally advanced non‐small cell lung cancer: A systematic review and meta‐analysis

Thoracic cancer, 2021-12, Vol.12 (23), p.3208-3215

2021

Volltextzugriff (PDF)

Effects of Tai Chi on Lower-Limb Myodynamia in the Elderly People： A Meta-Analysis

Journal of traditional Chinese medicine, 2011-06, Vol.31 (2), p.141-146

刘豹刘寨华朱慧儿莫家赐成东海

2011

Volltextzugriff (PDF)

Irradiated tumor cell-released microparticles enhance the therapeutic efficacy of PD-1 inhibitors by promoting M1-TAMs polarization in NSCLC brain metastases

Cancer letters, 2024-08, Vol.598, p.217133, Article 217133

2024

Volltextzugriff (PDF)

Radiation therapy for extensive-stage small-cell lung cancer in the era of immunotherapy

Cancer letters, 2022-08, Vol.541, p.215719-215719, Article 215719

2022

Volltextzugriff (PDF)

Investigation of reheat cracking susceptibility in CGHAZ of modified T23 steel

Journal of iron and steel research, international, 2021-11, Vol.28 (11), p.1417-1425

2021

Volltextzugriff (PDF)

Clinical outcomes of immune checkpoint blockades and the underlying immune escape mechanisms in squamous and adenocarcinoma NSCLC

Cancer medicine (Malden, MA), 2021-01, Vol.10 (1), p.3-14

2021

Volltextzugriff (PDF)

PD-1 inhibitor plus chemotherapy as 2nd/subsequent line therapy had similar clinical outcome with PD-1/PD-L1 inhibitor monotherapy in advanced NSCLC

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e21600-e21600

2020

Volltextzugriff (PDF)

Selecting optimal timing of cranial radiotherapy-based on the graded prognostic assessment for lung cancer using molecular markers (Lung-molGPA) in patients with non-small cell lung cancer and brain metastases

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e21105-e21105

2022

Volltextzugriff (PDF)

Prognostic value of cranial radiotherapy and optimal timing stratified by lung-molGPA for NSCLC patients with brain metastases

Journal of neuro-oncology, 2023-09, Vol.164 (2), p.321-330

2023

Volltextzugriff (PDF)

Outcomes of first-line anti-PD-L1 blockades combined with brain radiotherapy for extensive-stage small-cell lung cancer with brain metastasis

Journal of neuro-oncology, 2022-09, Vol.159 (3), p.685-693

2022

Volltextzugriff (PDF)

MTAP-deficiency could predict better treatment response in advanced lung adenocarcinoma patients initially treated with pemetrexed-platinum chemotherapy and bevacizumab

Scientific reports, 2020-01, Vol.10 (1), p.843-843, Article 843

2020

Volltextzugriff (PDF)

Recent advances and perspectives of postoperative neurological disorders in the elderly surgical patients

CNS neuroscience & therapeutics, 2022-04, Vol.28 (4), p.470-483

2022

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(45)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Feline umbilical cord-derived mesenchymal stem cells: isolation, identification, and antioxidative stress role through NF-κB signaling pathway

Potential immune escape mechanisms underlying the distinct clinical outcome of immune checkpoint blockades in small cell lung cancer

The Role of Cytokines in Predicting the Response and Adverse Events Related to Immune Checkpoint Inhibitors

The mechanism and risk factors for immune checkpoint inhibitor pneumonitis in non-small cell lung cancer patients

Somatostatin Treatment for Ectopic ACTH Syndrome due to Pancreatic Neuroendocrine Tumors: Review of the Literature

Downregulation of lncRNA XR_429159.1 Linked to Brain Metastasis in Patients With Limited-Stage Small-Cell Lung Cancer

Metabolic syndrome, intracranial arterial stenosis and cerebral small vessel disease in community-dwelling populations

Clinical Outcomes for PD-1 Inhibitor Plus Chemotherapy as Second-Line or Later Therapy Compared to PD-1/PD-L1 Inhibitor Alone in Advanced Non-small-cell Lung Cancer

Concurrent mutations of germline GPR101 and somatic USP8 in a pediatric giant pituitary ACTH adenoma: a case report

Therapeutic effect of osimertinib plus cranial radiotherapy compared to osimertinib alone in NSCLC patients with EGFR-activating mutations and brain metastases: a retrospective study

Identification of three novel SRD5A2 mutations in Chinese patients with 5α-reductase 2 deficiency

Comprehensive Treatment Uncertainty Analysis and PTV Margin Estimation for Fiducial Tracking in Robotic Liver Stereotactic Body Radiation Therapy

Identification of U-shaped curve relation between proneurotensin and risk of coronary artery disease (CAD) in patients with premature CAD

Endostar (rh‐endostatin) improves efficacy of concurrent chemoradiotherapy for locally advanced non‐small cell lung cancer: A systematic review and meta‐analysis

Effects of Tai Chi on Lower-Limb Myodynamia in the Elderly People： A Meta-Analysis

Irradiated tumor cell-released microparticles enhance the therapeutic efficacy of PD-1 inhibitors by promoting M1-TAMs polarization in NSCLC brain metastases

Radiation therapy for extensive-stage small-cell lung cancer in the era of immunotherapy

Investigation of reheat cracking susceptibility in CGHAZ of modified T23 steel

Clinical outcomes of immune checkpoint blockades and the underlying immune escape mechanisms in squamous and adenocarcinoma NSCLC

PD-1 inhibitor plus chemotherapy as 2nd/subsequent line therapy had similar clinical outcome with PD-1/PD-L1 inhibitor monotherapy in advanced NSCLC

Selecting optimal timing of cranial radiotherapy-based on the graded prognostic assessment for lung cancer using molecular markers (Lung-molGPA) in patients with non-small cell lung cancer and brain metastases

Prognostic value of cranial radiotherapy and optimal timing stratified by lung-molGPA for NSCLC patients with brain metastases

Outcomes of first-line anti-PD-L1 blockades combined with brain radiotherapy for extensive-stage small-cell lung cancer with brain metastasis

MTAP-deficiency could predict better treatment response in advanced lung adenocarcinoma patients initially treated with pemetrexed-platinum chemotherapy and bevacizumab

Recent advances and perspectives of postoperative neurological disorders in the elderly surgical patients

Suchergebnisse filtern